AIM
MNTA

Assured Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Assured Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,393
Closed -$267K – 1053
2019
Q1 		$267K Buy
18,393
+11,050
+150% +$141K ﹤0.01% 739
2018
Q4 		$81K Buy
7,343
+5,083
+225% +$70.7K ﹤0.01% 1002
2018
Q3 		$59K Buy
+2,260
New +$61.1K ﹤0.01% 1083
2018
Q2 		– Sell
-44,182
Closed -$802K – 1387
2018
Q1 		$802K Buy
+44,182
New +$737K 0.02% 617

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Assured Investment Management's MNTA Position: Q2 2019 in Review

Assured Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2019, closing a stake of 18,393 shares — an estimated $267K sold.

Assured Investment Management first reported a position in MNTA in Q1 2018 and held it in 4 quarters. The position peaked at $802K in Q1 2018. 155 funds tracked by Wall St. Rank hold MNTA as of Q2 2019.

  • Assured Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 18,393 Momenta Pharmaceuticals, Inc. shares in Q2 2019, an estimated $267K.
  • Assured Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 4 quarters.
  • Assured Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $802K in Q1 2018.
  • 155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.